Immunotherapy Toxicity Guidelines

• UK Oncology Nursing Society (UKONS)

  Initial management of adult cancer patient immmunotherapy toxicity guidelines

  • Endocrinpathies - Adrenal Crisis
  • Endocrinopathies - Hypophysitis
  • Endocrinopathies - Thyroid Dysfunction
  • Gastrointestinal
  • Hepatotoxicities
  • Neurological
  • Pneumonitis
  • Renal toxicity
  • Skin toxicities
  • Steroid tapering

• The Clatterbridge Cancer Centre Liverpool

  Subsequent Management of Immunotherapy Toxicity Guidance

  • Arthralgia
  • Colitis
  • Dermatitis
  • Hepatitis
  • Myocarditis
  • Nephritis
  • Pneumonitis

• Society for Endocrinology

  • Acute management of the endocrine complications of checkpoint inhibitor therapy

• Society for Gastroenterology

  • Management of immune checkpoint inhibitor-induced enterocolitis

• Joint British Diabetes Societies for Inpatient Care

  • Management of Hyperglycaemia and Steroid (Glucocorticoid) Therapy

• Cardiovascular Toxicity

  Baseline risk assessment and management of cardiovascular toxicities

  • Cardiovascular complications

• International Guidance

  • European Society of Medical Oncology (ESMO) - Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  • US Society for Immunotherapy of Cancer (SITC) - Immune Checkpoint Inhibitor-related Adverse Events Immunotherapy Guideline